As he explores the uses of psychedelic-assisted therapy, a physician continues to reframe and re-answer a niggling question about the ethos and mindset of practitioners of this new mode of treatment.
Jose Figueroa is an associate professor of health policy and management at the Harvard T.H. Chan School of Public Health and an assistant professor of medicine at Harvard Medical School.
For permission requests, please contact NEJM Reprints at [email protected] ...